(hard) Top 300 Drug Quiz 4 - Drugs #1-35 (Brand + Generic + Class + FDA)

amoxicillin FDA indications:

acute otitis media

lower respiratory tract infection

pharyngitis, tonsilitis

streptococcal pharyngitis

infection of ear, nose, throat, skin, subcutaneous tissue, or genitourinary system

H. pylori GI tract infection

amoxicillin/clavulanate FDA indications:

acute otitis media

community-acquired pneumonia

lower respiratory tract infection

sinusitis, infection of skin or subcutaneous tissue, infectious disease of genitourinary system

urinary tract infection, acute cystitis

urinary tract infection, pyelonephritis

azelastine FDA indications:

perennial allergic rhinitis

seasonal allergic rhinitis

vasomotor rhinitis

azithromycin FDA indications:

acute infective exacerbation of COPD, skin or tissue infection

bacterial sinusitis

chancroid, nongonococcal cervicitis, nongonococcal urethritis

community-acquired pneumonia

sexually transmitted infections

streptococcal pharyngitis

benazepril FDA indications:

hypertension

benzonatate FDA indications:

cough

canaglifozin FDA indications:

diabetes mellitus, type 2

chlorthalidone FDA indications:

hypertension

clarithromycin FDA indications:

acute infective exacerbation of bronchitis

community-acquired pneumonia, skin infection, sinusitis, pharyngitis

disseminated infection due to M. avium-intracellulare group, prophylaxis-HIV infection, primary prevention and treatment

H. pylori GI tract infection

streptococcal pharyngitis (group A)

COPD, acute exacerbation

dapagliflozin FDA indications:

diabetes mellitus, type 2

heart failure with reduced ejection fraction

diptheria toxoid FDA indications:

prevention of diptheria

dulaglutide FDA indications:

diabetes mellitus, type 2

enalapril FDA indications:

heart failure

hypertension

kidney disease, nondiabetic

epinephrine auto-injector FDA indications:

emergency treatment of acute anaphylaxis due to allergic reactions

exenatide FDA indications:

diabetes mellitus, type 2

ezetimibe FDA indications:

familial hypercholesterolemia-homozygous, with atorvastatin or simvastatin

mixed hyperlipidemia

primary hypercholesterolemia

fenofibrate FDA indications:

hypercholesterolemia primary hypercholesterolemia, or mixed dyslipidemia

hypertriglyceridemia, Frederickson types 4 and 5 hyperlipidemia

fidaxomicin FDA indications:

C. difficile infection

fosinopril FDA indications:

heart failure

hypertension

gemfibrozil FDA indications:

coronary arteriosclerosis; prophylaxis-familial combined hyperlipidemia

familial type V hyperlipoproteinemia-Fredrickson type IV hyperlipoproteinemia

haemophilus influenzae, type B vaccine FDA indications:

prevention of invasive H. influenzae type B infection

hydralazine FDA indications:

hypertension

hydrochlorothiazide FDA indications:

edema; adjunct

hypertension

liraglutide FDA indications:

diabetes mellitus, type 2

chronic weight management

lisinopril FDA indications:

ST-segment ejection MI

heart failure with reduced ejection fraction

hypertension

meclizine FDA indications:

motion sickenss

vertigo

meningococcal vaccine FDA indications:

prevention of invasive meningococcal disease caused by serotypes A, C, Y, W-135

prevention of invasive meningococcal disease caused by serotypes B

niacin FDA indications:

coronary arteriosclerosis, hypercholesterolemia

dyslipidemia

AMI, secondary prophylaxis

oseltamivir FDA indications:

influenza virus types A and B, treatment

influenza virus types A and B, prophylaxis

penicillin FDA indications:

bacterial endocarditis, prophylaxis in patients with congenital heart disease or rheumatic/acquired valvular heart disease

otitis media, mild-moderate, pneumococcal

streptococcal pharyngitis

erysipelas, mild infection or step-down therapy

pertussis vaccine FDA indications:

prevention of pertussis

pneumococcal vaccine FDA indications:

prevention of invasive pneumococcal disease

promethazine FDA indications:

motion sickness

allergy

nausea and vomiting

spironolactone FDA indications:

heart failure, NYHA class III-IV

edema associated with heart failure

nephrotic syndrome

hypertension

hypokalemia

triamterene/hydrochlorothiazide FDA indications:

edema

hypertension